Ajanta Pharma Ltd updates on USFDA inspection

Ajanta Pharma Limited has announced that the US FDA has concluded an inspection at our manufacturing facility at Paithan, in Maharashtra. The Inspection was conducted from April 13th, 2026, to April 21, 2026, and closed with the issuance of Form-483 with 5 (five) observations.

The Company will respond to the US FDA within the stipulated timeline.

Shares of Ajanta Pharma Limited was last trading in BSE at Rs. 2776.60 as compared to the previous close of Rs. 2795.90. The total number of shares traded during the day was 77256 in over 678 trades.

The stock hit an intraday high of Rs. 2811.20 and intraday low of 2750.00. The net turnover during the day was Rs. 213966454.00.

Source : Equity Bulls

Keywords

AjantaPharma INE031B01049 Pharmaceuticals USFDA Inspection